AI Reshapes Biotech CMC: Efficiency Gains, Governance Gaps, and Industry Realignment
How AI Enhances Efficiency in Biotech CMC Processes Over 65%: that’s the drop in laboratory deviations reported by biotech firms using AI in their CMC processes. There’s no denying it; this isn’t just
The successful integration of AI in CMC processes could redefine competitive dynamics in the biotech industry, favoring firms that can adeptly manage regulatory complexities.


